Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
Environ Int ; 94: 620-625, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27395334

ABSTRACT

BACKGROUND: Data on reproductive and developmental effects of extremely low frequency magnetic fields (ELF MFs) are inconclusive. This study tested the hypothesis that maternal exposure to ELF MFs is associated with increased time to pregnancy (TTP), reduced birthweight or small for gestational age (SGA). METHODS: The study cohort consisted of 373 mothers who gave birth between 1990 and 1994 in Kuopio University Hospital, Finland. To increase prevalence of high ELF MF exposure, women living in buildings near known ELF MF sources were included. Maternal exposure to ELF MF before and during pregnancy was assessed with short term measurements in residences and questionnaires. Associations between ELF MF exposure and TTP, low birth weight and SGA were analysed by logistic regression (or linear regression for continuous variables), adjusting for factors known to be associated with the selected pregnancy outcomes, such as maternal smoking, alcohol consumption and socioeconomic status. RESULTS: The MF exposure of the mothers was slightly higher than in Finnish residences in general, but very high exposures (>0.4µT) were rare. No consistent association of ELF MF with TTP, birth weight or SGA was found. CONCLUSIONS: ELF MF exposure is not likely to be associated with TTP or prenatal growth at residential exposure levels that were observable in this study.


Subject(s)
Fetal Development/radiation effects , Magnetic Fields , Maternal Exposure/statistics & numerical data , Time-to-Pregnancy/radiation effects , Cohort Studies , Female , Finland/epidemiology , Humans , Pregnancy
3.
Maturitas ; 63(1): 73-8, 2009 May 20.
Article in English | MEDLINE | ID: mdl-19394167

ABSTRACT

BACKGROUND: To analyse prospectively the effect of calcium or calcium+D supplementation on coronary heart disease (CHD) in 52-62-year-old women. METHODS AND RESULTS: 10,555 52-62-year-old women from the population-based Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE) who did not have CHD at baseline were followed for nearly 7 years in 1994-2001. Information about use of calcium supplements and health events was obtained from two repeated questionnaires in 1989 and 1994. Information about causes of death during the follow-up was obtained from the Statistics Finland. Information about CHD and other disease morbidity before and during the follow-up was obtained from the Registry of Specially Refunded Drugs of the Finnish Social Insurance Institution (SII). Cox's proportional-hazards models were used to estimate the risk of CHD morbidity related to the use of calcium supplements. At baseline, 2723 women reported current use of calcium or calcium+D supplementation. During the follow-up, CHD was diagnosed in 513 women. Compared to non-users of calcium/calcium+D supplements, the multivariate adjusted hazard ratio (HR) of CHD was 1.24 (95% CI 1.02-1.52) in women who used these supplements. The multivariate adjusted HR for CHD morbidity in postmenopausal women who used calcium/calcium+D supplements was 1.26 (95% CI 1.01-1.57). CONCLUSIONS: Calcium or calcium+D supplementation appears to increase the risk of CHD among women before old age.


Subject(s)
Calcium/adverse effects , Coronary Disease/chemically induced , Dietary Supplements/adverse effects , Osteoporosis, Postmenopausal/prevention & control , Vitamin D/adverse effects , Calcium/administration & dosage , Coronary Disease/epidemiology , Coronary Disease/mortality , Female , Finland/epidemiology , Humans , Middle Aged , Odds Ratio , Prevalence , Proportional Hazards Models , Prospective Studies , Risk Factors , Surveys and Questionnaires , Vitamin D/administration & dosage
4.
Eur J Endocrinol ; 160(6): 979-83, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19321660

ABSTRACT

OBJECTIVES: The purpose of this population-based prospective cohort study was to examine the effect of hormone therapy (HT) on incidence of diabetes mellitus (DM). DESIGN AND METHODS: Eight thousand four hundred and eighty-three DM-free post-menopausal women aged 52-62 from the population-based Kuopio osteoporosis risk factor and prevention study were followed for 5 years from 1994-1999. Information about the use of HT and health events was obtained from three repeated questionnaires in 1989, 1994, and 1999. DM morbidity before and during the follow-up was obtained from the Registry of Specially Refunded Drugs of the Finnish Social Insurance Institution. Kaplan-Meyer survival curves and Cox's proportional-hazards models were used to estimate the risk of incident DM in relation to the use of HT. RESULTS: During the follow-up, 40.8% DM-free post-menopausal women had never used HT, 27.3% women were HT past users and 31.9% women had used HT presently during the follow-up. During the follow-up, 162 incident DM cases were recorded. Compared with never users of HT, the adjusted hazard ratio of DM was 0.81 (95% confidence interval (CI) 0.57-1.16) for only past users, 0.53 (95% CI 0.24-1.15) in part-time (during the follow-up <2.5 years) users and 0.31 (95% CI 0.16-0.60) in continuous (during the follow-up 2.5-5.0 years) users of HT. CONCLUSIONS: HT use decreases the incidence of DM in post-menopausal women.


Subject(s)
Diabetes Mellitus, Type 1/prevention & control , Diabetes Mellitus, Type 2/prevention & control , Estrogen Replacement Therapy , Osteoporosis/prevention & control , Cohort Studies , Diabetes Mellitus, Type 1/epidemiology , Diabetes Mellitus, Type 2/epidemiology , Female , Finland/epidemiology , Humans , Incidence , Middle Aged , Osteoporosis/epidemiology , Postmenopause , Risk Factors , Treatment Outcome
5.
Cancer Causes Control ; 20(2): 163-70, 2009 Mar.
Article in English | MEDLINE | ID: mdl-18814048

ABSTRACT

Our objective was to compare the association between tobacco smoking and chewing and the risk of multiple human papillomavirus (HPV) infections and cervical squamous intraepithelial lesions (SILs) in two populations with different tobacco exposure. We studied 2,162 women from Côte d'Ivoire, West Africa, and 419 women from Finland, Northern Europe, with baseline data on cervical screening, HPV DNA status and smoking and chewing habits. The proportion of women who smoked and/or chewed tobacco was higher in Finland (36.8%) than in Côte d'Ivoire (3.7%), where tobacco chewing (2.6%) was more common than tobacco smoking (1.4%). Having multiple HPV infections was common in HPV16 and/or 18-infected women (60.4% in Finland and 47.2% in Côte d'Ivoire). There was no increased risk of multiple HPV infections among tobacco consumers. We found that women >or=30 years of age exposed to tobacco through smoking in Finland (OR: 2.2, 95% CI: 0.5-8.7) and chewing in Côte d'Ivoire (OR: 5.5, 95% CI: 2.1-14) had a moderately or highly increased risk of high-grade SIL, respectively. In the latter, the risk was statistically significant. Our findings emphasize the need for health initiatives targeted to prevent tobacco smoking or chewing among women especially in less industrialized countries.


Subject(s)
Neoplasms, Squamous Cell/virology , Papillomavirus Infections/etiology , Smoking/adverse effects , Tobacco, Smokeless/adverse effects , Uterine Cervical Dysplasia/virology , Uterine Cervical Neoplasms/virology , Adult , Cote d'Ivoire , Cross-Sectional Studies , Female , Finland , Humans , Papillomavirus Infections/epidemiology , Prevalence , Risk Factors
6.
Maturitas ; 61(1-2): 85-94, 2008.
Article in English | MEDLINE | ID: mdl-19434882

ABSTRACT

OBJECTIVES: We investigated the incidence of new non-vertebral fractures during HRT or low-dose vitamin (Vit) D3 supplementation in a 5-year prospective trial. METHODS: A total of 464 early postmenopausal women, (a subgroup of the Kuopio Osteoporosis Study, n = 13100) were randomized to four groups: (1) HRT, a sequential combination of 2 mg estradiol valerate and 1 mg cyproterone acetate; (2) Vit D (300 IU/day and 100 IU/day during the fifth year); (3) HRT + Vit D; and (4) placebo. Lumbar (L2-4) and femoral neck bone mineral densities (BMD) were determined by dual X-ray absorptiometry (DXA) at baseline, after 2.5 and 5 years of treatment. All new symptomatic non-vertebral, radiographically defined fractures were recorded. RESULTS: Altogether, 368 women (79%) completed the 5 year treatment. In all, 32 women had 39 non-vertebral fractures during a mean of 4.3 year follow-up (HRT 4, Vit D 10, HRT + Vit D 8 and placebo 17). The reduction in the incidence of new non-verterbral fractures was significant in women with HRT alone (P = 0.032) when adjusted by baseline BMD and previous fractures; observed also with the intention-to-treat principle (P = 0.048). When the HRT groups were pooled, HRT showed a significantly lower incidence of new non-vertebral fractures (P = 0.042) than women receiving placebo and also after adjusting as above (P = 0.016); both in valid-case and in the intention-to-treat analysis. In the Vit D group, the fracture incidence was non-significantly decreased (P = 0.229) in comparison with the placebo group. The estimated risk of new non-vertebral fractures among women treated with HRT alone was 0.29 (95% CI, 0.10-0.90) and with Vit D 0.47 (95% CI, 0.20-1.14) and with HRT + Vit D 0.44 (95% CI, 0.17-1.15), in comparison with the placebo group (adjusted by femoral BMD and previous fractures). CONCLUSIONS: This study is the first prospective trial confirming the beneficial effect of HRT on prevention of peripheral fractures in non-osteoporotic postmenopausal women. The effect of low-dose Vit D remains to be proved.

7.
Eur J Cancer ; 43(8): 1300-7, 2007 May.
Article in English | MEDLINE | ID: mdl-17448653

ABSTRACT

AIM: The aim of the present study was to clarify prognostic role of angiogenesis in epithelial ovarian cancer. METHODS: Quantification of angiogenesis was performed by the Chalkley method after immunostaining of 175 epithelial ovarian cancer specimens with an antibody against CD34. RESULTS: The Chalkley count was categorised into two groups according to the median value: low <8 or high > or =8. The low Chalkley count correlated significantly with serous and clear cell histological subtype of the tumour (p<0.0005), whereas there existed no association with FIGO (International Federation of Gynecology and Obstetrics) stage, histological grade, presence of primary residual tumour, age at diagnosis, or chemotherapy response. In univariate analysis, the high Chalkley count predicted poor overall survival in the subgroup of patients with FIGO stages III-IV tumours (p=0.007) but not in the entire study cohort. However, in multivariate analysis, the Chalkley count was found to be an independent predictor of death from ovarian cancer in the entire study cohort (p=0.044, RR=1.50, 95% CI 1.01-2.21) as well as in the subgroup of FIGO stages III-IV tumours (p=0.046, RR=1.58, 95% CI 1.01-2.46) together with the presence of primary residual tumour (p<0.0005, RR=5.10, 95% CI 3.02-8.62, and p=0.002, RR=4.28, 95% CI 1.34-13.73, respectively). CONCLUSIONS: The Chalkley count seems to be suitable for evaluation of angiogenesis and to have prognostic significance in ovarian cancer.


Subject(s)
Antigens, CD34/metabolism , Neovascularization, Pathologic/pathology , Ovarian Neoplasms/blood supply , Adult , Age of Onset , Aged , Aged, 80 and over , Disease-Free Survival , Female , Humans , Immunohistochemistry , Middle Aged , Neovascularization, Pathologic/metabolism , Ovarian Neoplasms/metabolism , Prognosis , Survival Analysis
8.
Gynecol Oncol ; 105(1): 97-103, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17174383

ABSTRACT

OBJECTIVE: To study the association of inducible nitric oxide synthase (iNOS) expression with clinicopathological factors and prognosis in epithelial ovarian cancer. METHODS: The study included 301 patients with primary epithelial ovarian cancer. iNOS expression was evaluated by immunohistochemistry using a mouse monoclonal antibody. RESULTS: iNOS positivity was observed as granular deposits in the cancer cell cytoplasm. The mean percentage of iNOS-positive cells was 50% in primary tumors (n=301), and 62% in metastatic lesions (n=43). iNOS expression correlated significantly with histological subtype of the tumor, as high (> 70%) iNOS expression was observed in mucinous tumors (p=0.009). Poorly differentiated tumors showed a tendency to low (< or = 70%) iNOS expression but without statistical significance. Low iNOS expression associated also significantly with large primary residual tumor (p=0.007) and tumor recurrence (p=0.04). The 10-year prognosis of the patients with high iNOS expression was better in disease-related survival (DRS) (p=0.009). However, in multivariate analysis only FIGO stage, primary residual tumor, and grade of the tumor were independent prognostic factors for DRS, but not the iNOS expression. CONCLUSIONS: A major proportion of human epithelial ovarian cancers expressed iNOS. The positive expression was an indicator of better disease-related survival. However, iNOS positivity could not overcome the importance of clinicopathological factors in prediction of prognosis.


Subject(s)
Nitric Oxide Synthase Type II/biosynthesis , Ovarian Neoplasms/enzymology , Adolescent , Adult , Aged , Aged, 80 and over , Epithelial Cells/pathology , Female , Humans , Immunohistochemistry , Middle Aged , Multivariate Analysis , Neoplasm Staging , Ovarian Neoplasms/pathology , Prognosis
9.
Int J Psychoanal ; 87(Pt 5): 1335-53, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16997729

ABSTRACT

For Freud, body ego was the organizing basis of the structural theory. He defined it as a psychic projection of the body surface. Isakower's and Lewin's classical findings suggest that the body surface experiences of nursing provide the infant with sensory-affective stimulation that initiates a projection of sensory processes towards the psychic realm. During nursing, somato-sensory, gustatory and olfactory modalities merge with a primitive somatic affect of satiation, whereas auditory modality is involved more indirectly and visual contact more gradually. Repeated regularly, such nascent experiences are likely to play a part in the organization of the primitive protosymbolic mental experience. In support of this hypothesis, the authors review findings from a neurophysiological study of infants before, during and after nursing. Nursing is associated with a significant amplitude change in the newborn electroencephalogram (EEG), which wanes before the age of 3 months, and is transformed at the age of 6 months into rhythmic 3-5 Hz hedonic theta-activity. Sucking requires active physiological work, which is shown in a regular rise in heart rate. The hypothesis of a sensory-affective organization of the nascent body ego, enhanced by nursing and active sucking, seems concordant with neurophysiological phenomena related to nursing.


Subject(s)
Body Image , Ego , Freudian Theory , Neurophysiology , Psychology, Child , Affect/physiology , Brain/physiology , Breast Feeding/psychology , Electroencephalography , Heart Rate/physiology , Humans , Infant , Infant, Newborn , Metaphysics , Projection , Satiation/physiology , Sucking Behavior/physiology
10.
Inform Prim Care ; 14(1): 41-7, 2006.
Article in English | MEDLINE | ID: mdl-16848965

ABSTRACT

OBJECTIVE: The aim of this study was to find out what aspects of their parenthood parents revealed, and how they expressed their thoughts concerning maternity care services on an online communication forum. BACKGROUND: The 'Information Society' offers a growing variety of health services as part of public primary health care via the internet. Little is known about the contents produced online by pregnant families, and how they reflect on both family life and maternity care services. METHODS: The data for this study were obtained from online discussions between families (n=21) in Net Clinic, an internet-based service designed for public maternity care. The data included experiences of family life during pregnancy, childbirth and parenting, and was analysed by inductive content analysis. RESULTS: While maturing into parenthood, both women and men recognised the uniqueness of their new role and wanted to prepare for safe childbirth. Online communication in the home environment nourished new social networks among families who were expecting their first, second or third child. In addition, families reflected on maternity care services on the Net Clinic's communication forum. This provided realistic feedback to maternity care professionals. CONCLUSIONS: Today, the relationship between clients and professionals is inevitably changing. More online services and advocacy are needed if families are to have access to online health services. The role of professionals is diversifying from being authorities to supporting and facilitating clients' individual self-care. Based on direct client feedback, the quality of maternity care can be improved.


Subject(s)
Family Relations , Internet , Maternal Health Services , Parents/psychology , Pregnancy/psychology , Self-Help Groups , Adult , Female , Finland , Humans , Male , Middle Aged
11.
J Bone Miner Metab ; 24(4): 314-8, 2006.
Article in English | MEDLINE | ID: mdl-16816926

ABSTRACT

Ospemifene is a novel selective estrogen receptor modulator (SERM) that is initially being developed for the treatment of vaginal atrophy in postmenopausal women. However, it also shows promise in the prevention and treatment of osteoporosis. As a part of a phase II trial, we compared the effects of ospemifene and raloxifene on bone turnover in postmenopausal women. The study was conducted as a randomized, double-blind study in which 118 healthy postmenopausal women received 30 (n = 29), 60 (n = 30), or 90 mg (n = 30) ospemifene or 60 mg (n = 29) raloxifene for 3 months. Bone resorption was assessed by measuring the urinary outputs of N- and C-terminal cross-linking telopeptides of type I collagen (NTX and CTX, respectively). Bone formation was assessed by measuring bone-specific alkaline phosphatase (bone ALP), osteocalcin (OC), procollagen type I N propeptide (PINP), and procollagen type I C propeptide (PICP) in serum. All markers were studied before and at 3 months and 2-4 weeks after cessation of the medication. Urine NTX outputs decreased in all study groups, and the only statistically significant difference in NTX was observed between raloxifene and 30 mg ospemifene, which was reduced more in the raloxifene group. The output of CTX decreased most clearly in 60- and 90-mg ospemifene groups, but no significant differences between study groups emerged. A significant difference was found between the 90-mg ospemifene group and raloxifene in PINP in favor of ospemifene. No other differences in bone formation markers emerged between ospemifene and raloxifene. The study confirms the bone-restoring activity of ospemifene, which is comparable to that of raloxifene.


Subject(s)
Bone Remodeling/drug effects , Postmenopause/metabolism , Raloxifene Hydrochloride/pharmacology , Tamoxifen/analogs & derivatives , Biomarkers/metabolism , Bone Remodeling/physiology , Collagen/urine , Double-Blind Method , Female , Finland , Humans , Osteoporosis, Postmenopausal/drug therapy , Tamoxifen/pharmacology
12.
J Midwifery Womens Health ; 51(4): 279-283, 2006.
Article in English | MEDLINE | ID: mdl-16814223

ABSTRACT

The aim of this research was to analyze conversations between expectant families (N = 21) in Net Clinic, an Internet-based service designed for patients using public maternity care. The online conversations, shared opinions about experiences of pregnancy, and family life constituted the data for content analysis. The families developed a sense of virtual community, which gradually evolved into a real-life community, by discovering the similarity of their life situations and by giving parent-to-parent support for everyday life events. As a view of daily family life, Net Clinic offers maternity care professionals a deeper understanding of how to enhance safer pregnancy, birth, and growth of the family.


Subject(s)
Community Networks/organization & administration , Family , Internet , Maternal Health Services/methods , Self-Help Groups , Adult , Emotions , Female , Finland , Health Education/methods , Health Knowledge, Attitudes, Practice , Humans , Male , Middle Aged , Pilot Projects , Pregnancy , Trust
13.
Maturitas ; 53(3): 333-42, 2006 Feb 20.
Article in English | MEDLINE | ID: mdl-16019169

ABSTRACT

OBJECTIVES: Fracture risk and bone mineral density (BMD) among peri- and early postmenopausal women with leiomyomas requiring hysterectomy was evaluated. METHODS: We counted fractures among women with or without leiomyomas using data from the Kuopio Osteoporosis Study. The study population consisted of 6086 women aged 47-56 years with never-use of hormone replacement therapy (HRT) responding to the baseline and 5-year follow-up inquiries. Part of the sample (n=1271) underwent bone densitometry. RESULTS: Hysterectomy was carried out in 927 women, and 59% reported that this was attributable to leiomyomas. The hazard ratio (HR) was 0.68 (95% CI 0.49-0.94) for any and 0.73 (95% CI 0.43-1.26) for distal forearm fracture among women with leiomyomas compared to those without any. Among women postmenopausal at baseline, the corresponding HRs were 0.62 (95% CI 0.44-0.87) and 0.54 (95% CI 0.31-0.96); after adjusting for age, time since menopause weight, height and previous fracture 0.69 (95% CI 0.49-0.97) and 0.63 (95% CI 0.35-1.11). The baseline BMDs were 1.15 g/cm2 among hysterectomized leiomyoma and 1.12 g/cm2 (ns) among non-hysterectomized women at lumbar (L2-L4), and 0.94 and 0.93 g/cm2 (ns) at femoral sites. The follow-up lumbar BMDs were 1.13 and 1.09 g/cm2 (p<0.001) and the corresponding femoral values were 0.90 and 0.89 g/cm2 (ns), respectively. Among postmenopausal women, the corresponding baseline lumbar BMDs were 1.15 and 1.08 g/cm2 (p<0.001), femoral 0.93 and 0.90 g/cm2 (p=0.003); the follow-up lumbar BMDs 1.13 g/cm2 versus 1.07 g/cm2 (p<0.001); femoral BMDs 0.89 versus 0.87 (ns). CONCLUSIONS: Peri- and early postmenopausal women with a history of leiomyomas seem to have better BMD and less fractures compared with those without leiomyomas. This may be mediated through higher estrogen levels leading to higher BMD and the growth of leiomyomas.


Subject(s)
Bone Density/physiology , Fractures, Bone/etiology , Leiomyoma/physiopathology , Perimenopause/physiology , Postmenopause/physiology , Uterine Neoplasms/physiopathology , Absorptiometry, Photon , Female , Follow-Up Studies , Fractures, Bone/epidemiology , Fractures, Bone/prevention & control , Humans , Hysterectomy , Leiomyoma/complications , Leiomyoma/surgery , Middle Aged , Ovariectomy , Prospective Studies , Risk Factors , Surveys and Questionnaires , Uterine Neoplasms/complications , Uterine Neoplasms/surgery
14.
Eur J Endocrinol ; 154(1): 101-7, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16381998

ABSTRACT

OBJECTIVES: To analyze prospectively the association between hormone replacement therapy (HRT) and mortality in women before old age. DESIGN AND METHODS: A group of 11,667 women (91% of the age cohort of the area) aged 52-62 years from the population-based Kuopio Osteoporosis Risk Factor and Prevention Study were followed for 7 years in 1994-2001. Information about HRT use and health events was obtained from two repeated questionnaires in 1989 and 1994. Information about deaths and causes of death from the follow-up period was obtained from the Statistics Finland. Cox's proportional-hazards models were used to calculate risk of death related to the use of HRT. RESULTS: At the start of follow-up, 2203 women had used HRT > 5 years, 3945 women < or = 5 years and 5519 women had never used it. During the follow-up, 361 deaths occurred. Compared with non-users of HRT, the adjusted hazard ratio (HR) of death from any cause was 1.05 (95% confidence interval (CI) 0.80-1.36) in women who used HRT < or = 5 years and 1.06 (95% CI 0.78-1.46) in women who used HRT > 5 years. The adjusted HR for coronary heart disease (CHD) mortality in women who used HRT < or = 5 years was 0.79 (95% CI 0.36-1.73), and in women who used HRT > 5 years, 2.16 (95% CI 0.93-4.98). For breast cancer mortality the adjusted HR for < or = 5 years of HRT use was 0.96 (95% CI 0.32-2.82) and 2.62 (95% CI 0.98-7.00) for > 5 years of HRT use. CONCLUSIONS: History of HRT use does not affect overall or CHD mortality in women. More than 5 years of HRT use may increase the risk of breast cancer mortality.


Subject(s)
Breast Neoplasms/mortality , Coronary Disease/mortality , Estrogen Replacement Therapy , Aged , Cohort Studies , Estradiol/administration & dosage , Estradiol/adverse effects , Estrogen Replacement Therapy/adverse effects , Female , Finland/epidemiology , Humans , Levonorgestrel/administration & dosage , Levonorgestrel/adverse effects , Middle Aged , Multivariate Analysis , Norethindrone/administration & dosage , Norethindrone/adverse effects , Norethindrone/analogs & derivatives , Norethindrone Acetate , Postmenopause , Prospective Studies
15.
Osteoporos Int ; 16(11): 1404-11, 2005 Nov.
Article in English | MEDLINE | ID: mdl-15739033

ABSTRACT

Only a few studies have examined the risk of individual chronic health disorders on perimenopausal (i.e., around menopause) fractures in a single study. We evaluated the effect of chronic illnesses on fracture rate in a prospective cohort study of 3,078 women. These women were a stratified sample from the population base of 14,220 women aged 47-56 years and residing in the province of Kuopio in eastern Finland in 1989. Data on physician-diagnosed chronic diseases were collected by a baseline questionnaire in 1989. For certain diseases, questionnaire information of self-reported chronic disorders were compared with drug reimbursement data provided by the Social Insurance Institution of Finland. Axial bone mineral density (BMD) measurements from the femoral neck and lumbar spine were performed in 1989-91. Two hundred sixty-five (265) women experienced at least one fracture during the follow-up period of 3.6 years (SD+/-0.78). The first fracture during the follow-up period was taken to be the end-point event. The risk of follow-up fracture for an individual health disorder was estimated with the Cox's proportional hazards model. Several chronic health disorders increased the fracture risk in perimenopausal women. However, hypertension was a statistically significant (p=0.018) risk factor for fracture (adjusted hazard ratio [HR], 1.4; 95% confidence interval [CI], 1.1-1.9), especially in overweight and obese (body mass index > or =28) women (HR, 2.0; 95% CI, 1.4-3.0). In addition, coronary heart disease (adjusted HR, 1.76; 95% CI, 1.13-2.76), hyperthyroidism (adjusted HR, 1.7; 95% CI, 1.0-2.9), epilepsy (adjusted HR, 2.0; 95% CI, 1.1-3.6), alcoholism (adjusted HR, 3.5; 95% CI, 1.3-9.5) and chronic hepatic disease (adjusted HR, 5.2; 95% CI, 1.7-16.4) predicted fracture. BMD was either normal or even elevated in disease groups. However, women with a fracture during the follow-up usually had decreased bone density, although the difference was statistically significant only in women with hypertension and hyperthyroidism. We conclude that hypertension, coronary heart disease, alcoholism, epilepsy and hyperthyroidism can markedly increase the risk of fracture in perimenopausal women and should be taken into account when assessing the risk of future fracture in an individual patient. Furthermore, in contrast to previous data, obesity alone does not increase the risk of perimenopausal fracture, but in association with hypertension the risk seems to be markedly elevated.


Subject(s)
Chronic Disease/epidemiology , Fractures, Bone/epidemiology , Menopause , Absorptiometry, Photon , Bone Density , Cohort Studies , Female , Femur Neck/diagnostic imaging , Finland/epidemiology , Fractures, Bone/prevention & control , Humans , Lumbar Vertebrae/diagnostic imaging , Middle Aged , Proportional Hazards Models , Prospective Studies , Recurrence
16.
Bone ; 35(3): 589-94, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15336593

ABSTRACT

Neuropeptide Y (NPY) is a versatile neurotransmitter that has recently been shown to regulate bone metabolism in animal and in vitro studies. We studied the influence of leucine7-to-proline7 (Leu7/Pro7) polymorphism of the NPY signal peptide gene on bone mineral density (BMD) before and after a 5-year hormone replacement therapy (HRT) in 316 early postmenopausal women participating in a randomized controlled trial nested in the population-based Kuopio Osteoporosis Risk Factor and Prevention (OSTPRE) study. The participants were randomized into two treatment groups: the HRT group (n = 146) received a sequential combination of 2 mg estradiol valerate and 1 mg cyproterone acetate and calcium lactate, 500 mg/day (equal to 93 mg Ca2+) alone or in combination with vitamin D3, 100-300 IU/day. The non-HRT group (n = 170) received calcium lactate, 500 mg alone or in combination with vitamin D3, 100-300 IU/day. BMDs of the lumbar spine (L2-4) and proximal femur were measured by using dual X-ray absorptiometry (DXA). The frequency of Leu7/Pro7 polymorphism was 15.2%. At baseline, there were no significant differences in the lumbar or femoral neck BMD between the subjects who had Leu7Pro7 polymorphism and the normal subjects. After 5 years, the BMD of the femoral neck remained unaltered and that of the lumbar spine increased by 1.7% in the HRT group, whereas both BMDs were decreased by 4-5% in the non-HRT group. After 5 years, the femoral neck BMD was significantly lower in those with the wild-type NPY polymorphism than in those with Leu7/Pro7 polymorphism (P = 0.040) in the non-HRT group. In the HRT group, the changes in BMD were quite modest and not significantly modified by Leu7/Pro7 genotype. We conclude that the Leu7/Pro7 polymorphism in NPY signal gene may favorably affect femoral neck BMD in postmenopausal women.


Subject(s)
Bone Density/genetics , Leucine/genetics , Neuropeptide Y/genetics , Polymorphism, Genetic , Postmenopause/genetics , Proline/genetics , Protein Precursors/genetics , Protein Sorting Signals/genetics , Estrogen Replacement Therapy , Female , Femur Neck/physiology , Follow-Up Studies , Humans , Middle Aged
17.
Eur J Appl Physiol ; 93(1-2): 102-7, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15316789

ABSTRACT

The aim of the present study was to investigate cross-sectionally the association of postmenopausal muscle strength with simple performance tests. A random sample of 1,166 naturally postmenopausal women (born 1932-1941) was selected from the Kuopio Osteoporosis Risk Factor and Prevention (OSTPRE) study cohort. Grip and quadriceps strength were measured with strain gauge dynamometers and reported in both absolute values (KPa and kg) and per kilogram of body mass (N cm(-2) kg(-1) and N kg(-1)). In addition, two performance tests, 'ability to stand on one foot' and 'ability to squat down to touch the floor' were carried out. A five-category self-assessment of overall health ('very good', 'good', 'moderate', 'bad', and 'very bad') was obtained by postal questionnaire. The women that were able to stand on one foot and able to squat down to touch the floor had greater grip and quadriceps strength than their counterparts ( P<0.001 and P<0.03 in ANOVA, respectively). In addition, self-assessed health had a strong positive association with muscle strength in the grip and leg extensor muscles in ANOVA ( P<0.001 between 'very good' and 'moderate' or poorer state of health) and regression model ( P<0.001). Adjustment for age, duration of menopause, body mass, height, physical activity level, use of HRT, and number of diseases and medications did not change any of the main effects. Also, there were no differences in results between absolute measurement values and values reported per kilogram of body mass. According to the present study, a simple performance test may be useful in the prediction of postmenopausal muscle strength. Furthermore, self-assessed state of health is strongly associated with muscle strength in postmenopausal women.


Subject(s)
Body Constitution/physiology , Motor Skills/physiology , Muscle Contraction/physiology , Muscle, Skeletal/physiology , Physical Exertion/physiology , Postmenopause/physiology , Postural Balance/physiology , Cohort Studies , Cross-Sectional Studies , Female , Finland/epidemiology , Humans , Middle Aged
18.
Fetal Diagn Ther ; 19(4): 336-41, 2004.
Article in English | MEDLINE | ID: mdl-15192293

ABSTRACT

OBJECTIVE: To assess obstetric outcome in women with a history of placental abruption. METHODS: We utilised the population-based birth registry data of Kuopio University Hospital to investigate pregnancy outcome in 59 women with prior placental abruption. The general obstetric population was used as a reference group in logistic regression analysis. RESULTS: Recurrent placental abruption and associated adverse neonatal outcome occurred in 11.9% (7:59) of the women. If the disease did not recur, a history of placental abruption had no significant effects on birth weight, fetal distress or prematurity rate, whereas the incidence of pre-eclampsia was found to be increased. CONCLUSIONS: Women in whom placental abruption does not recur have a good outcome in their subsequent delivery, almost comparable to that in the general obstetric population. However, the recurrence rate of 11.9% is high (OR: 16.9, 95% CI: 8.2-34.9) when compared with the background incidence of placental abruption (0.7%).


Subject(s)
Abruptio Placentae/diagnosis , Abruptio Placentae/epidemiology , Adult , Chi-Square Distribution , Confidence Intervals , Cross-Sectional Studies , Female , Humans , Logistic Models , Multivariate Analysis , Odds Ratio , Pregnancy , Pregnancy Outcome/epidemiology , Prognosis , Retrospective Studies
19.
Clin Cancer Res ; 9(14): 5318-24, 2003 Nov 01.
Article in English | MEDLINE | ID: mdl-14614016

ABSTRACT

PURPOSE: The purpose of this study was to investigate the expression and prognostic significance of CD44 in epithelial ovarian cancer. EXPERIMENTAL DESIGN: We analyzed the expression of CD44 by immunohistochemistry in 307 epithelial ovarian cancers and evaluated its relation to hyaluronan, clinicopathological factors, and prognosis. RESULTS: Fifty-one percent of the tumors had a high proportion of CD44-positive cells (i.e., >/==" BORDER="0">10%), and this high CD44 expression was significantly associated with cancer cell-associated hyaluronan, well-differentiated tumor, mucinous histological type, and early stage of the tumor. High CD44 expression predicted better 5-year overall survival (50% versus 22%) and recurrence-free survival (70% versus 34%) in the univariate analyses (P < 0.00005 for both). In the Cox multivariate analyses, the independent predictors of overall survival at 5 years were primary residual tumor (P < 0.0005), International Federation of Gynecologists and Obstetricians (FIGO) stage (P = 0.001), histological grade (P = 0.014), adjuvant chemotherapy (P = 0.004), and stromal hyaluronan level (P < 0.0005), but not CD44. However, the expression of CD44 (P = 0.04) and stromal hyaluronan (P = 0.005) were both independent predictors of recurrence-free survival at 5 years, together with the size of the primary residual tumor (P < 0.0005) and histological type (P = 0.043). CONCLUSIONS: The relatively frequent ectopic expression of CD44 on ovarian cancer cells is thus related to well-differentiated, early-stage tumor and long survival of the patients. Thus, whereas CD44-expressing cancer cells may adhere and implant to the hyaluronan-positive mesothelium, at least in model systems, high expression of CD44 in the tumor does not bring about an unfavorable prognosis.


Subject(s)
Hyaluronan Receptors/metabolism , Hyaluronic Acid/metabolism , Neoplasms, Glandular and Epithelial/metabolism , Ovarian Neoplasms/metabolism , Adenocarcinoma, Mucinous/drug therapy , Adenocarcinoma, Mucinous/metabolism , Adenocarcinoma, Mucinous/pathology , Biomarkers, Tumor/metabolism , Carcinoma, Endometrioid/drug therapy , Carcinoma, Endometrioid/metabolism , Carcinoma, Endometrioid/pathology , Cell Differentiation , Chemotherapy, Adjuvant , Cystadenocarcinoma, Serous/drug therapy , Cystadenocarcinoma, Serous/metabolism , Cystadenocarcinoma, Serous/pathology , Epithelium/metabolism , Female , Finland , Humans , Middle Aged , Neoplasm Recurrence, Local/drug therapy , Neoplasm Recurrence, Local/metabolism , Neoplasm Recurrence, Local/pathology , Neoplasms, Glandular and Epithelial/drug therapy , Neoplasms, Glandular and Epithelial/pathology , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/pathology , Prognosis , Stromal Cells/metabolism , Survival Rate
20.
Int J Cancer ; 107(3): 359-64, 2003 Nov 10.
Article in English | MEDLINE | ID: mdl-14506734

ABSTRACT

Versican, a proteoglycan previously reported to increase in other malignant tumours, was studied immunohistochemically in 299 primary epithelial ovarian cancers, their 43 metastases and 6 normal ovaries to evaluate its prognostic value and relation to hyaluronan, another extracellular matrix molecule increased in cancer and a binding partner of versican. The stainings were scored according to the area percentage of strong versican signal of total peri- and intratumoural stroma as low (<15%) or high (>or=15%). Epithelial staining of the tumours was scored as positive or negative. Low and high area percentage of strong stromal versican staining were observed in 133 and 166 carcinomas, respectively. A low area percentage of strong stromal versican staining correlated with mucinous histology (p = 0.019) and early International Federation of Gynecologists and Obstetritians (FIGO) stage (p < 0.0005), whereas a high percentage was associated with reduced 5-year survival rate of the patients (44% vs. 32%; p = 0.032). Versican was associated with the cancer cells in 151 tumours and correlated with clear cell histology (p < 0.0005), early FIGO stage (p = 0.049) and increased recurrence-free survival (63% vs. 47%; p = 0.032). However, in Cox's multivariate analyses with the conventional prognostic factors included, neither stromal nor cancer cell-associated versican reached a significant prognostic value. Versican is thus enriched in the malignant stroma surrounding and promoting the growth of ovarian cancer, probably acting with hyaluronan, and associates with unfavourable prognosis but does not constitute an independent indicator of patient survival.


Subject(s)
Chondroitin Sulfate Proteoglycans/analysis , Hyaluronic Acid/analysis , Neoplasms, Glandular and Epithelial/chemistry , Ovarian Neoplasms/chemistry , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Immunohistochemistry , Lectins, C-Type , Middle Aged , Neoplasms, Glandular and Epithelial/mortality , Neoplasms, Glandular and Epithelial/pathology , Ovarian Neoplasms/mortality , Ovarian Neoplasms/pathology , Prognosis , Survival Rate , Versicans
SELECTION OF CITATIONS
SEARCH DETAIL
...